1. HER2 targeted breast cancer treatment has significantly improved prognosis. 2. Novel immune checkpoint therapies have resulted in considerable clinical response for a variety of cancer types. Evidence Rating Level: 2 (Good) Study Rundown: Cancer therapy is a continually evolving field, as researchers strive to determine the most effective methods of treating this complex disease. […]
Original Article: Paradigm shift in cancer treatment to targeted therapies